Chapter 1. ANALGESICS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. ANALGESICS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3. ANALGESICS MARKET –  Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. ANALGESICS MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. ANALGESICS MARKET -  Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. ANALGESICS MARKET – By Drug Class

6.1. Acetaminophen

6.2. Local Anaesthetics

6.3. NSAIDs

6.4. Opioids

Chapter 7. ANALGESICS MARKET – By Indication

7.1. Cancer Pain

7.2. Neuropathic Pain

7.3. Surgical Pain

Chapter 8. ANALGESICS MARKET – By Route Of Administration

8.1. Parenteral

8.2. Oral

8.3. Transdermal

Chapter 9. ANALGESICS MARKET – By Distribution Channel

9.1. Drug Stores

9.2. Retail Pharmacies

9.3. Hospital Pharmacies

9.4. Clinics

9.5. Others

Chapter 10. ANALGESICS MARKET – By Region

10.1. North America

10.2. Europe

10.3. Asia - Pacific

10.4. Latin America

10.5. The Middle East

10.6. Africa

Chapter 11. ANALGESICS MARKET – By Companies

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company 10